Nasus Pharma Ltd Shareholders' Equity
Nasus Pharma Ltd (NSRX) had Shareholders' Equity of $2.77 million as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-03-25
- 2025-12-31: Stockholders' Equity Attributable to Parent $2.77M.
- 2025-06-30: Stockholders' Equity Attributable to Parent -$4.31M.
- 2024-12-31: Stockholders' Equity Attributable to Parent -$3.21M.
- 2024-06-30: Stockholders' Equity Attributable to Parent -$4.66M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-12-31 | $2.77M 20-F · filed 2026-03-25 |
| 2025-06-30 | -$4.31M 6-K · filed 2025-12-29 |
| 2024-12-31 | -$3.21M 20-F · filed 2026-03-25 |
| 2024-06-30 | -$4.66M 6-K · filed 2025-12-29 |
| 2023-12-31 | -$3.80M 20-F · filed 2026-03-25 |
| 2022-12-31 | -$2.79M 20-F · filed 2026-03-25 |